TCL Archive In Brief: Training Act Requires 75% Fr Institutional Grants, Rest For Individuals Fellowships September 27, 1974
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003